Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Husain

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Journal of the National Cancer Institute|December 16, 1992
Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cellsA Rahman, S R Husain, J Siddiqui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapyMariko Kawakami, Koji Kawakami, Vitaly A Stepensky, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1991
Sixth mycelial fraction acetone (6-MFA), an interferon inducer modulates acrylamide neurotoxicityR Husain, V K Khanna, S I Zaidi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Protective effect of 6-MFA, an interferon inducer against acrylamide neurotoxicityR Husain, V K Khanna, S A Mall, et al.
Journal of Translational Medicine|February 21, 2013
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signalingBradford Hall, Hideyuki Nakashima, Zhi-Jun Sun, et al.
Human Gene Therapy Methods|May 23, 2012
Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13Wu Ou, Michael P Marino, Akiko Suzuki, et al.
Blood|May 15, 1996
Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)R K Puri, P Leland, N I Obiri, et al.
The British Journal of Ophthalmology|December 20, 2005
Visual acuity after acute primary angle closure and considerations for primary lens extractionG S W Tan, S-T Hoh, R Husain, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2011
Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumorsHideyuki Nakashima, Kotaro Miyake, Christopher R Clark, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Mechanisms for improving walking speed after longitudinal powered robotic exoskeleton training for individuals with spinal cord injuryArvind Ramanujam, Kamyar Momeni, Syed R Husain, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Journal of the National Cancer Institute|December 16, 1992
Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cellsA Rahman, S R Husain, J Siddiqui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapyMariko Kawakami, Koji Kawakami, Vitaly A Stepensky, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1991
Sixth mycelial fraction acetone (6-MFA), an interferon inducer modulates acrylamide neurotoxicityR Husain, V K Khanna, S I Zaidi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Protective effect of 6-MFA, an interferon inducer against acrylamide neurotoxicityR Husain, V K Khanna, S A Mall, et al.
Journal of Translational Medicine|February 21, 2013
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signalingBradford Hall, Hideyuki Nakashima, Zhi-Jun Sun, et al.
Human Gene Therapy Methods|May 23, 2012
Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13Wu Ou, Michael P Marino, Akiko Suzuki, et al.
Blood|May 15, 1996
Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)R K Puri, P Leland, N I Obiri, et al.
The British Journal of Ophthalmology|December 20, 2005
Visual acuity after acute primary angle closure and considerations for primary lens extractionG S W Tan, S-T Hoh, R Husain, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2011
Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumorsHideyuki Nakashima, Kotaro Miyake, Christopher R Clark, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Mechanisms for improving walking speed after longitudinal powered robotic exoskeleton training for individuals with spinal cord injuryArvind Ramanujam, Kamyar Momeni, Syed R Husain, et al.
Pageof 14